• The Norwegian tenecteplase stroke trial (NOR-TEST): Randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke 

      Logallo, Nicola; Kvistad, Christopher Elnan; Nacu, Aliona; Næss, Halvor; Waje-Andreassen, Ulrike; Assmus, Jørg; Aamodt, Anne Hege; Lund, Christian; Kurz, Friedrich Martin W.; Rønning, Ole M.; Salvesen, Rolf; Idicula, Titto; Thomassen, Lars (Journal article; Tidsskriftartikkel; Peer reviewed, 2014)
    • Safety and Outcomes of Tenecteplase in Moderate and Severe Ischemic Stroke. Results From NOR-TEST 

      Kvistad, Christopher Elnan; Novotny, Vojtech; Kurz, Martin; Rønning, Ole M.; Thommessen, Bente; Carlsson, Maria; Waje-Andreassen, Ulrike; Næss, Halvor; Thomassen, Lars; Logallo, Nicola (Journal article; Tidsskriftartikkel; Peer reviewed, 2019-04-08)
      <p><i>Background and Purpose — </i>Tenecteplase represents a promising alternative to alteplase as thrombolytic treatment in acute ischemic stroke. There are limited data on tenecteplase 0.4 mg/kg in patients with increased stroke severity. We aimed to assess safety and efficacy of tenecteplase 0.4 mg/kg in patients with moderate and severe ischemic stroke. <p><i>Methods — </i>NOR-TEST (Norwegian ...